Skip to main content
Capricor Therapeutics, Inc. (CAPR)
NASDAQ: CAPR · Real-Time Price · USD
13.07
+0.17 (1.32%)
At close: Dec 20, 2024, 4:00 PM
13.10
+0.03 (0.23%)
After-hours: Dec 20, 2024, 7:53 PM EST

Capricor Therapeutics Revenue

Capricor Therapeutics had revenue of $2.26M in the quarter ending September 30, 2024, a decrease of -63.44%. This brings the company's revenue in the last twelve months to $23.23M, up 65.33% year-over-year. In the year 2023, Capricor Therapeutics had annual revenue of $25.18M with 886.81% growth.

Revenue (ttm)
$23.23M
Revenue Growth
+65.33%
P/S Ratio
17.87
Revenue / Employee
$227,726
Employees
102
Market Cap
594.29M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202325.18M22.63M886.81%
Dec 31, 20222.55M2.31M941.85%
Dec 31, 2021244.90K-65.35K-21.06%
Dec 31, 2020310.25K-694.78K-69.13%
Dec 31, 20191.01M-666.33K-39.87%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Cross Country Healthcare 1.45B
Varex Imaging 811.00M
Fulgent Genetics 277.76M
Surmodics 126.08M
GRAIL 117.67M
Simulations Plus 70.01M
Autolus Therapeutics 10.09M
Altimmune 52.00K
Revenue Rankings

CAPR News

More News